25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ATNF (180 Life Sciences Corp) Stock Analysis
Buy, Hold or Sell?

Let's analyze 180 Life Sciences Corp together

I guess you are interested in 180 Life Sciences Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – 180 Life Sciences Corp’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – 180 Life Sciences Corp’s Price Targets

I'm going to help you getting a better view of 180 Life Sciences Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about 180 Life Sciences Corp

I send you an email if I find something interesting about 180 Life Sciences Corp.

1. Quick Overview

1.1. Quick analysis of 180 Life Sciences Corp (30 sec.)










1.2. What can you expect buying and holding a share of 180 Life Sciences Corp? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
3.7%

What is your share worth?

Current worth
$1.35
Expected worth in 1 year
$2.87
How sure are you?
51.9%

+ What do you gain per year?

Total Gains per Share
$1.52
Return On Investment
163.8%

For what price can you sell your share?

Current Price per Share
$0.93
Expected price per share
$0.658 - $1.3
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of 180 Life Sciences Corp (5 min.)




Live pricePrice per Share (EOD)
$0.93
Intrinsic Value Per Share
$-0.30 - $0.24
Total Value Per Share
$1.06 - $1.60

2.2. Growth of 180 Life Sciences Corp (5 min.)




Is 180 Life Sciences Corp growing?

Current yearPrevious yearGrowGrow %
How rich?$7.7m$1.3m$3.6m72.9%

How much money is 180 Life Sciences Corp making?

Current yearPrevious yearGrowGrow %
Making money-$1.8m-$4m$2.1m117.5%
Net Profit Margin0.0%-345.8%--

How much money comes from the company's main activities?

2.3. Financial Health of 180 Life Sciences Corp (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#618 / 881

Most Revenue
#790 / 881

Most Profit
#287 / 881

Most Efficient
#225 / 881
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of 180 Life Sciences Corp?

Welcome investor! 180 Life Sciences Corp's management wants to use your money to grow the business. In return you get a share of 180 Life Sciences Corp.

First you should know what it really means to hold a share of 180 Life Sciences Corp. And how you can make/lose money.

Speculation

The Price per Share of 180 Life Sciences Corp is $0.9282. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of 180 Life Sciences Corp.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in 180 Life Sciences Corp, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.35. Based on the TTM, the Book Value Change Per Share is $0.38 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.36 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of 180 Life Sciences Corp.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.42-44.8%-0.33-35.3%-0.71-76.8%-0.73-78.2%-0.62-66.6%-0.59-63.2%
Usd Book Value Change Per Share-0.27-29.3%0.3841.0%-0.36-38.3%-0.49-52.3%0.022.4%0.055.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.032.8%0.022.0%
Usd Total Gains Per Share-0.27-29.3%0.3841.0%-0.36-38.3%-0.49-52.3%0.055.2%0.077.4%
Usd Price Per Share0.98-1.53-1.08-1.43-3.52-5.27-
Price to Earnings Ratio-0.59-48.85--0.97-15.82-9.14--62.29-
Price-to-Total Gains Ratio-3.61-4.52-6.04-3.40-5.85-7.89-
Price to Book Ratio0.72--4.52--11.46--5.04--0.93--1.97-
Price-to-Total Gains Ratio-3.61-4.52-6.04-3.40-5.85-7.89-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.9282
Number of shares1077
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.03
Usd Book Value Change Per Share0.380.02
Usd Total Gains Per Share0.380.05
Gains per Quarter (1077 shares)409.4051.94
Gains per Year (1077 shares)1,637.59207.78
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101638162811097198
2032753266221195406
3049134904331292614
4065506542441390822
50818881805524871030
60982698186625851238
7011463114567736821446
8013101130948837791654
9014738147329938771862
100163761637011049742070

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%2.010.00.016.7%5.015.00.025.0%7.020.00.025.9%7.020.00.025.9%
Book Value Change Per Share3.01.00.075.0%5.07.00.041.7%10.010.00.050.0%13.014.00.048.1%13.014.00.048.1%
Dividend per Share0.00.04.00.0%0.00.012.00.0%1.00.019.05.0%1.00.026.03.7%1.00.026.03.7%
Total Gains per Share3.01.00.075.0%5.07.00.041.7%11.09.00.055.0%14.013.00.051.9%14.013.00.051.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of 180 Life Sciences Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.2720.380-171%-0.355+31%-0.486+79%0.023-1301%0.050-642%
Book Value Per Share--1.3530.890+52%0.241+462%1.655-18%2.779-51%4.496-70%
Current Ratio--1.0220.816+25%0.640+60%0.856+19%0.632+62%0.584+75%
Debt To Asset Ratio--0.3390.591-43%0.960-65%0.632-46%0.561-40%0.541-37%
Debt To Equity Ratio--0.5120.674-24%0.259+98%0.510+0%1.545-67%1.237-59%
Dividend Per Share----0%-0%-0%0.026-100%0.019-100%
Enterprise Value--5360885.2006496259.450-17%2531387.308+112%4516844.958+19%16853704.749-68%34810378.600-85%
Eps---0.416-0.328-21%-0.713+71%-0.726+75%-0.618+49%-0.587+41%
Ev To Ebitda Ratio---0.565-0.740+31%-0.519-8%-0.489-13%-2.782+393%-10.102+1689%
Free Cash Flow Per Share---0.150-0.057-62%-0.355+137%-0.341+128%-0.353+135%-0.297+98%
Free Cash Flow To Equity Per Share---0.1500.132-214%-0.087-42%-0.029-81%-0.018-88%-0.010-93%
Gross Profit Margin--1.0000.491+104%1.010-1%0.834+20%0.900+11%0.926+8%
Intrinsic Value_10Y_max--0.244----------
Intrinsic Value_10Y_min---0.295----------
Intrinsic Value_1Y_max---1.165----------
Intrinsic Value_1Y_min---1.145----------
Intrinsic Value_3Y_max---2.594----------
Intrinsic Value_3Y_min---2.494----------
Intrinsic Value_5Y_max---2.930----------
Intrinsic Value_5Y_min---2.797----------
Market Cap5286553.818-6%5581580.2008714099.700-36%6161096.308-9%8139804.458-31%27327329.049-80%35436134.785-84%
Net Profit Margin----0%-3.4580%-1.1530%-0.6920%-0.5120%
Operating Margin----0%-3.7730%-1.2580%-0.7550%-0.5590%
Operating Ratio----0%5.024-100%1.675-100%1.005-100%0.744-100%
Pb Ratio0.686-6%0.724-4.523+724%-11.458+1682%-5.044+796%-0.933+229%-1.966+371%
Pe Ratio-0.558+5%-0.58948.846-101%-0.972+65%15.821-104%9.144-106%-62.286+10475%
Price Per Share0.928-6%0.9801.530-36%1.082-9%1.429-31%3.516-72%5.272-81%
Price To Free Cash Flow Ratio-1.548+5%-1.634-2.940+80%-1.094-33%-1.588-3%-21.280+1202%-25.418+1455%
Price To Total Gains Ratio-3.419+5%-3.6104.519-180%6.043-160%3.403-206%5.850-162%7.893-146%
Quick Ratio--0.9550.648+47%0.421+127%0.669+43%0.673+42%44.227-98%
Return On Assets---0.203-0.154-24%-0.721+255%-0.458+125%-0.296+46%-0.246+21%
Return On Equity---0.307-0.248-19%-0.137-55%-0.407+32%-0.691+125%-0.549+79%
Total Gains Per Share---0.2720.380-171%-0.355+31%-0.486+79%0.048-663%0.069-493%
Usd Book Value--7705572.0005068317.500+52%1371069.250+462%9425681.667-18%16734354.600-54%26277718.333-71%
Usd Book Value Change Per Share---0.2720.380-171%-0.355+31%-0.486+79%0.023-1301%0.050-642%
Usd Book Value Per Share--1.3530.890+52%0.241+462%1.655-18%2.779-51%4.496-70%
Usd Dividend Per Share----0%-0%-0%0.026-100%0.019-100%
Usd Enterprise Value--5360885.2006496259.450-17%2531387.308+112%4516844.958+19%16853704.749-68%34810378.600-85%
Usd Eps---0.416-0.328-21%-0.713+71%-0.726+75%-0.618+49%-0.587+41%
Usd Free Cash Flow---853723.000-325218.250-62%-2021437.250+137%-1942597.250+128%-2259734.150+165%-1879700.370+120%
Usd Free Cash Flow Per Share---0.150-0.057-62%-0.355+137%-0.341+128%-0.353+135%-0.297+98%
Usd Free Cash Flow To Equity Per Share---0.1500.132-214%-0.087-42%-0.029-81%-0.018-88%-0.010-93%
Usd Market Cap5286553.818-6%5581580.2008714099.700-36%6161096.308-9%8139804.458-31%27327329.049-80%35436134.785-84%
Usd Price Per Share0.928-6%0.9801.530-36%1.082-9%1.429-31%3.516-72%5.272-81%
Usd Profit---2369232.000-1866916.250-21%-4060694.500+71%-5730207.750+142%-4390904.100+85%-4336148.185+83%
Usd Revenue----0%83015.000-100%27671.667-100%16603.000-100%12298.519-100%
Usd Total Gains Per Share---0.2720.380-171%-0.355+31%-0.486+79%0.048-663%0.069-493%
 EOD+3 -5MRQTTM+11 -22YOY+22 -133Y+22 -135Y+17 -2010Y+15 -22

3.3 Fundamental Score

Let's check the fundamental score of 180 Life Sciences Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.558
Price to Book Ratio (EOD)Between0-10.686
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.955
Current Ratio (MRQ)Greater than11.022
Debt to Asset Ratio (MRQ)Less than10.339
Debt to Equity Ratio (MRQ)Less than10.512
Return on Equity (MRQ)Greater than0.15-0.307
Return on Assets (MRQ)Greater than0.05-0.203
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of 180 Life Sciences Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.830
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About 180 Life Sciences Corp

180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases in the United States. The company product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed phase 2a and phase 2b proof-of-concept clinical trials for early-stage Dupuytren's Contracture; and Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain. 180 Life Sciences Corp. is headquartered in Palo Alto, California.

Fundamental data was last updated by Penke on 2025-06-19 00:06:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ 180 Life Sciences Corp earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ 180 Life Sciences Corp to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of 180 Life Sciences Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-345.8%+345.8%
TTM-5Y-69.2%+69.2%
5Y-69.2%10Y-51.2%-17.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--88.2%+88.2%
TTM--141.5%+141.5%
YOY-345.8%-182.9%-162.9%
3Y-115.3%-247.7%+132.4%
5Y-69.2%-338.6%+269.4%
10Y-51.2%-473.1%+421.9%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ 180 Life Sciences Corp is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ 180 Life Sciences Corp to theΒ Biotechnology industry mean.
  • -20.3% Return on Assets means thatΒ 180 Life Sciences Corp generatedΒ $-0.20 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of 180 Life Sciences Corp:

  • The MRQ is -20.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -15.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-20.3%TTM-15.4%-5.0%
TTM-15.4%YOY-72.1%+56.7%
TTM-15.4%5Y-29.6%+14.2%
5Y-29.6%10Y-24.6%-5.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-20.3%-11.1%-9.2%
TTM-15.4%-11.2%-4.2%
YOY-72.1%-11.0%-61.1%
3Y-45.8%-11.6%-34.2%
5Y-29.6%-11.8%-17.8%
10Y-24.6%-13.6%-11.0%
4.3.1.3. Return on Equity

Shows how efficient 180 Life Sciences Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ 180 Life Sciences Corp to theΒ Biotechnology industry mean.
  • -30.7% Return on Equity means 180 Life Sciences Corp generated $-0.31Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of 180 Life Sciences Corp:

  • The MRQ is -30.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -24.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-30.7%TTM-24.8%-5.9%
TTM-24.8%YOY-13.7%-11.1%
TTM-24.8%5Y-69.1%+44.3%
5Y-69.1%10Y-54.9%-14.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-30.7%-12.8%-17.9%
TTM-24.8%-14.2%-10.6%
YOY-13.7%-14.1%+0.4%
3Y-40.7%-16.6%-24.1%
5Y-69.1%-17.3%-51.8%
10Y-54.9%-19.4%-35.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of 180 Life Sciences Corp.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient 180 Life Sciences Corp is operatingΒ .

  • Measures how much profit 180 Life Sciences Corp makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ 180 Life Sciences Corp to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of 180 Life Sciences Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-377.3%+377.3%
TTM-5Y-75.5%+75.5%
5Y-75.5%10Y-55.9%-19.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--227.4%+227.4%
TTM--253.9%+253.9%
YOY-377.3%-201.7%-175.6%
3Y-125.8%-214.9%+89.1%
5Y-75.5%-339.9%+264.4%
10Y-55.9%-444.7%+388.8%
4.3.2.2. Operating Ratio

Measures how efficient 180 Life Sciences Corp is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of 180 Life Sciences Corp:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY5.024-5.024
TTM-5Y1.005-1.005
5Y1.00510Y0.744+0.261
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.060-2.060
TTM-2.737-2.737
YOY5.0242.997+2.027
3Y1.6753.496-1.821
5Y1.0054.660-3.655
10Y0.7446.353-5.609
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of 180 Life Sciences Corp.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if 180 Life Sciences Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 1.02Β means the company has $1.02 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of 180 Life Sciences Corp:

  • The MRQ is 1.022. The company is just able to pay all its short-term debts.
  • The TTM is 0.816. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ1.022TTM0.816+0.206
TTM0.816YOY0.640+0.176
TTM0.8165Y0.632+0.184
5Y0.63210Y0.584+0.048
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0223.670-2.648
TTM0.8163.745-2.929
YOY0.6404.121-3.481
3Y0.8564.623-3.767
5Y0.6325.733-5.101
10Y0.5846.143-5.559
4.4.3.2. Quick Ratio

Measures if 180 Life Sciences Corp is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ 180 Life Sciences Corp to theΒ Biotechnology industry mean.
  • A Quick Ratio of 0.96Β means the company can pay off $0.96 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of 180 Life Sciences Corp:

  • The MRQ is 0.955. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.648. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.955TTM0.648+0.307
TTM0.648YOY0.421+0.227
TTM0.6485Y0.673-0.025
5Y0.67310Y44.227-43.554
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9552.906-1.951
TTM0.6483.128-2.480
YOY0.4213.786-3.365
3Y0.6694.308-3.639
5Y0.6735.703-5.030
10Y44.2276.411+37.816
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of 180 Life Sciences Corp.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of 180 Life Sciences CorpΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ 180 Life Sciences Corp to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.34Β means that 180 Life Sciences Corp assets areΒ financed with 33.9% credit (debt) and the remaining percentage (100% - 33.9%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of 180 Life Sciences Corp:

  • The MRQ is 0.339. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.591. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.339TTM0.591-0.252
TTM0.591YOY0.960-0.369
TTM0.5915Y0.561+0.030
5Y0.56110Y0.541+0.020
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3390.328+0.011
TTM0.5910.356+0.235
YOY0.9600.335+0.625
3Y0.6320.339+0.293
5Y0.5610.350+0.211
10Y0.5410.383+0.158
4.5.4.2. Debt to Equity Ratio

Measures ifΒ 180 Life Sciences Corp is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ 180 Life Sciences Corp to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 51.2% means that company has $0.51 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of 180 Life Sciences Corp:

  • The MRQ is 0.512. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.674. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.512TTM0.674-0.162
TTM0.674YOY0.259+0.415
TTM0.6745Y1.545-0.871
5Y1.54510Y1.237+0.308
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5120.384+0.128
TTM0.6740.436+0.238
YOY0.2590.413-0.154
3Y0.5100.447+0.063
5Y1.5450.464+1.081
10Y1.2370.512+0.725
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings 180 Life Sciences Corp generates.

  • Above 15 is considered overpriced butΒ always compareΒ 180 Life Sciences Corp to theΒ Biotechnology industry mean.
  • A PE ratio of -0.59 means the investor is paying $-0.59Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of 180 Life Sciences Corp:

  • The EOD is -0.558. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.589. Based on the earnings, the company is expensive. -2
  • The TTM is 48.846. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD-0.558MRQ-0.589+0.031
MRQ-0.589TTM48.846-49.435
TTM48.846YOY-0.972+49.818
TTM48.8465Y9.144+39.702
5Y9.14410Y-62.286+71.430
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.558-2.125+1.567
MRQ-0.589-2.027+1.438
TTM48.846-2.541+51.387
YOY-0.972-3.670+2.698
3Y15.821-3.716+19.537
5Y9.144-6.057+15.201
10Y-62.286-6.591-55.695
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of 180 Life Sciences Corp:

  • The EOD is -1.548. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.634. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.940. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.548MRQ-1.634+0.086
MRQ-1.634TTM-2.940+1.306
TTM-2.940YOY-1.094-1.846
TTM-2.9405Y-21.280+18.340
5Y-21.28010Y-25.418+4.137
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.548-3.030+1.482
MRQ-1.634-2.710+1.076
TTM-2.940-3.805+0.865
YOY-1.094-4.404+3.310
3Y-1.588-5.103+3.515
5Y-21.280-8.536-12.744
10Y-25.418-9.228-16.190
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ 180 Life Sciences Corp is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 0.72 means the investor is paying $0.72Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of 180 Life Sciences Corp:

  • The EOD is 0.686. Based on the equity, the company is cheap. +2
  • The MRQ is 0.724. Based on the equity, the company is cheap. +2
  • The TTM is -4.523. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.686MRQ0.724-0.038
MRQ0.724TTM-4.523+5.247
TTM-4.523YOY-11.458+6.936
TTM-4.5235Y-0.933-3.590
5Y-0.93310Y-1.966+1.033
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.6861.900-1.214
MRQ0.7241.861-1.137
TTM-4.5232.162-6.685
YOY-11.4582.465-13.923
3Y-5.0442.527-7.571
5Y-0.9333.682-4.615
10Y-1.9664.351-6.317
4.6.2. Total Gains per Share

2.4. Latest News of 180 Life Sciences Corp

Does 180 Life Sciences Corp still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from 180 Life Sciences Corp to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-06-25
23:38
180 Life Sciences schedules annual meeting for July 24, sets proposal deadlineRead
2025-06-20
22:26
180 Life Sciences announces $500M mixed shelf offeringRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of 180 Life Sciences Corp.

4.8.1. Institutions holding 180 Life Sciences Corp

Institutions are holding 10.39% of the shares of 180 Life Sciences Corp.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Geode Capital Management, LLC0.2622014933149330
2025-03-31XTX Topco Ltd0.21690.000612352123520
2024-12-31UBS Group AG0.1258071643174.6298
2025-03-31BlackRock Inc0.0099056400
2025-03-31Citigroup Inc0.002901631630
2025-03-31Group One Trading, LP0.000905300
2025-03-31SBI Securities Co Ltd0.000703826216.6667
2025-03-31Bank of America Corp0.000301600
2025-03-31Mccormack Advisors International0.00010330
2025-03-31Semmax Financial Advisors Inc.0021100
2025-03-31Tower Research Capital LLC000-6744-100
2024-12-31Northern Trust Investments N A000-67-100
2025-03-31Rathbone Brothers PLC000-69995-100
2025-03-31FMR Inc000-1-100
2025-03-31Hudson Bay Capital Management LP000-150024-100
2025-03-31Anson Funds Management LP000-225271-100
2024-12-31Virtu Financial LLC000-14088-100
2025-03-31IFP Advisors, LLC000-50-100
Total 0.61970.000635288-438445-1,242.5%

4.9.2. Funds holding 180 Life Sciences Corp

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-04-30Fidelity Extended Market Index0.212501210400
2025-04-30Fidelity Series Total Market Index0.04970282900
2025-04-30Vanguard Institutional Extnd Mkt Idx Tr0.04430252100
2025-03-31Northern Trust Extended Eq Market Idx0.000904900
2025-03-31NT Ext Equity Mkt Idx Fd - L0.000904900
2025-03-31NT Ext Equity Mkt Idx Fd - NL0.000804800
2025-03-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.0006037-1-2.6316
2025-05-31State St US Extended Mkt Indx NL Cl C0.000301700
2025-03-31BNYM Mellon SL Market Completion UC10.000301500
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T40.0002012120
2025-03-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.000201200
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T30.0002012120
2025-03-31Northern Trust Wilshire 50000.00020900
2025-05-31State St US Ttl Mkt Indx NL Cl A0.00010800
2025-03-31SSgA U.S. Total Market Index Strategy0.00010700
2025-03-31BNYM Mellon NSL Mkt Completion Fund Inst00200
Total 0.3113017731+23+0.1%

5.3. Insider Transactions

Insiders are holding 36.769% of the shares of 180 Life Sciences Corp.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-05-31Jr. Donald A McgovernBUY52621.85
2023-05-18James N WoodyBUY210519.57
2023-05-18Ozan PamirBUY27119.19
2023-05-18Pamela G MarroneBUY37220.14
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2024-03-312024-06-302024-09-302024-12-312025-03-31
Other Current Liabilities  1,471-8036673,1533,820-2,3961,424-1,880-456



5.2. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets11,651
Total Liabilities3,945
Total Stockholder Equity7,706
 As reported
Total Liabilities 3,945
Total Stockholder Equity+ 7,706
Total Assets = 11,651

Assets

Total Assets11,651
Total Current Assets4,029
Long-term Assets7,622
Total Current Assets
Cash And Cash Equivalents 3,725
Net Receivables 41
Other Current Assets 304
Total Current Assets  (as reported)4,029
Total Current Assets  (calculated)4,070
+/- 41
Long-term Assets
Intangible Assets 7,622
Long-term Assets  (as reported)7,622
Long-term Assets  (calculated)7,622
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities3,942
Long-term Liabilities3
Total Stockholder Equity7,706
Total Current Liabilities
Short-term Debt 148
Short Long Term Debt 148
Accounts payable 2,125
Other Current Liabilities -456
Total Current Liabilities  (as reported)3,942
Total Current Liabilities  (calculated)1,966
+/- 1,976
Long-term Liabilities
Long term Debt 3
Long-term Liabilities  (as reported)3
Long-term Liabilities  (calculated)3
+/-0
Total Stockholder Equity
Common Stock1
Retained Earnings -143,893
Accumulated Other Comprehensive Income -2,982
Other Stockholders Equity 154,579
Total Stockholder Equity (as reported)7,706
Total Stockholder Equity (calculated)7,706
+/-0
Other
Capital Stock1
Cash and Short Term Investments 3,725
Common Stock Shares Outstanding 3,539
Liabilities and Stockholders Equity 11,651
Net Debt -3,576
Net Invested Capital 7,857
Net Working Capital 87
Short Long Term Debt Total 148



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
> Total Assets 
116,813
117,026
117,058
117,308
117,955
118,221
0
66,471
946
51,458
51,884
12,368
50,372
11,024
50,372
60,112
56,265
65,070
62,714
59,677
53,358
34,336
19,650
14,922
13,667
4,958
5,259
3,442
3,911
10,470
12,763
11,651
11,65112,76310,4703,9113,4425,2594,95813,66714,92219,65034,33653,35859,67762,71465,07056,26560,11250,37211,02450,37212,36851,88451,45894666,4710118,221117,955117,308117,058117,026116,813
   > Total Current Assets 
608
486
470
391
597
543
0
567
501
828
748
83
553
721
553
8,298
4,046
13,634
11,201
8,957
4,647
6,515
8,928
4,196
2,934
3,371
3,640
1,855
2,347
1,225
5,141
4,029
4,0295,1411,2252,3471,8553,6403,3712,9344,1968,9286,5154,6478,95711,20113,6344,0468,298553721553837488285015670543597391470486608
       Cash And Cash Equivalents 
578
454
428
340
543
519
0
-567
157
78
83
-83
70
474
70
6,053
1,836
11,688
8,225
5,669
1,625
3,589
6,970
2,646
2,009
2,663
1,976
676
1,146
195
4,585
3,725
3,7254,5851951,1466761,9762,6632,0092,6466,9703,5891,6255,6698,22511,6881,8366,0537047470-838378157-5670519543340428454578
       Short-term Investments 
116,206
116,540
116,588
116,917
117,358
117,678
0
1,134
0
0
0
167
0
10,303
10,303
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000010,30310,30301670001,1340117,678117,358116,917116,588116,540116,206
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
328
328
357
0
357
300
300
0
695
0
2,035
2,510
621
357
89
130
279
10
10
0
41
41
414101010279130893576212,5102,0350695030030035703573283280000000000
       Inventory 
0
0
0
0
0
0
0
0
0
0
0
302
119
0
0
0
1,107
0
2,232
0
976
-2,510
-621
-621
-89
-130
0
0
0
0
0
0
000000-130-89-621-621-2,51097602,23201,10700011930200000000000
   > Long-term Assets 
116,206
116,540
116,588
116,917
117,358
117,678
0
-567
445
50,630
51,136
-83
49,820
10,303
49,820
51,814
52,220
51,436
51,513
50,721
48,710
27,821
10,722
10,726
10,732
1,587
1,620
1,587
1,564
9,244
7,622
7,622
7,6227,6229,2441,5641,5871,6201,58710,73210,72610,72227,82148,71050,72151,51351,43652,22051,81449,82010,30349,820-8351,13650,630445-5670117,678117,358116,917116,588116,540116,206
       Property Plant Equipment 
0
0
0
0
0
0
0
22
21
57
54
54
44
0
44
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000004404454545721220000000
       Goodwill 
0
0
0
0
0
0
0
0
0
36,010
36,423
36,423
35,339
0
35,339
37,183
37,561
36,896
36,988
36,324
34,589
13,966
0
0
0
0
0
0
0
0
0
0
000000000013,96634,58936,32436,98836,89637,56137,18335,339035,33936,42336,42336,010000000000
       Intangible Assets 
0
0
0
0
0
0
0
404
406
1,969
14,659
14,659
14,436
0
14,436
14,631
14,658
14,540
14,525
14,397
14,121
13,855
10,722
10,726
10,732
1,587
1,620
1,587
1,564
9,244
7,622
7,622
7,6227,6229,2441,5641,5871,6201,58710,73210,72610,72213,85514,12114,39714,52514,54014,65814,63114,436014,43614,65914,6591,9694064040000000
       Long-term Assets Other 
116,206
116,540
116,588
116,917
117,358
117,678
0
-567
18
12,594
0
-83
0
10,303
10,303
0
12,570
12,569
-9,712
12,530
12,411
12,291
-15,656
-15,656
9,063
0
0
0
0
0
0
0
00000009,063-15,656-15,65612,29112,41112,530-9,71212,56912,570010,30310,3030-83012,59418-5670117,678117,358116,917116,588116,540116,206
> Total Liabilities 
4,138
4,264
4,233
4,309
4,745
4,691
0
5,203
2,128
6,961
13,314
7,238
14,490
4,003
14,490
37,403
53,549
27,929
23,391
18,773
10,566
8,261
8,306
7,783
6,951
5,107
5,387
4,396
4,329
6,736
3,512
3,945
3,9453,5126,7364,3294,3965,3875,1076,9517,7838,3068,26110,56618,77323,39127,92953,54937,40314,4904,00314,4907,23813,3146,9612,1285,20304,6914,7454,3094,2334,2644,138
   > Total Current Liabilities 
113
239
208
284
720
666
0
1,178
2,128
6,961
9,641
3,213
8,060
4,003
8,060
33,622
49,799
24,225
19,699
15,077
6,966
4,725
5,658
5,122
4,273
4,807
5,063
4,080
4,016
6,384
3,505
3,942
3,9423,5056,3844,0164,0805,0634,8074,2735,1225,6584,7256,96615,07719,69924,22549,79933,6228,0604,0038,0603,2139,6416,9612,1281,1780666720284208239113
       Short-term Debt 
0
0
0
0
0
0
0
0
140
2,005
3,528
3,528
586
2,720
586
1,707
1,564
361
1,909
1,383
889
406
1,309
842
588
333
1,300
772
429
473
148
148
1481484734297721,3003335888421,3094068891,3831,9093611,5641,7075862,7205863,5283,5282,00514000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
586
0
3,668
1,707
1,564
361
1,909
1,383
889
406
1,309
842
588
333
1,034
772
429
3,246
148
148
1481483,2464297721,0343335888421,3094068891,3831,9093611,5641,7073,6680586000000000000
       Accounts payable 
0
0
0
0
0
0
0
213
1,384
2,389
4,104
4,104
4,714
358
4,714
3,905
2,530
639
587
1,039
1,591
1,015
1,801
1,208
837
1,713
1,893
1,837
2,920
2,091
1,933
2,125
2,1251,9332,0912,9201,8371,8931,7138371,2081,8011,0151,5911,0395876392,5303,9054,7143584,7144,1044,1042,3891,3842130000000
       Other Current Liabilities 
113
132
120
212
541
603
0
1,044
-153
4,544
2,009
3,193
-1,180
898
2,760
24,385
45,704
23,226
17,203
12,655
4,486
3,303
2,548
3,072
2,848
2,761
3,762
1,471
667
3,820
1,424
-456
-4561,4243,8206671,4713,7622,7612,8483,0722,5483,3034,48612,65517,20323,22645,70424,3852,760898-1,1803,1932,0094,544-1531,0440603541212120132113
   > Long-term Liabilities 
4,025
4,025
4,025
4,025
4,025
4,025
0
4,025
4,025
4,025
3,673
4,025
6,430
6,251
6,430
3,781
3,750
3,704
3,692
3,696
3,600
3,536
2,649
2,661
2,678
301
325
316
313
352
7
3
373523133163253012,6782,6612,6493,5363,6003,6963,6923,7043,7503,7816,4306,2516,4304,0253,6734,0254,0254,02504,0254,0254,0254,0254,0254,025
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,484
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000003,48400000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
3,673
0
3,484
2,022
3,711
3,673
3,680
3,652
3,644
3,652
3,563
3,504
0
0
2,651
0
0
0
0
0
0
0
00000002,651003,5043,5633,6523,6443,6523,6803,6733,7112,0223,48403,6730000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
12,537
0
0
0
12,570
12,589
12,615
3,652
12,576
12,530
12,411
12,291
0
0
9,063
0
0
0
0
0
0
0
00000009,0630012,29112,41112,53012,5763,65212,61512,58912,57000012,5370000000000
> Total Stockholder Equity
5,000
5,000
5,000
5,000
5,000
5,000
0
-7,677
-1,182
40,811
38,571
38,571
35,882
5,000
35,882
22,709
2,716
37,141
39,323
40,905
42,791
26,075
11,344
7,140
6,716
-149
-128
-954
-418
3,734
9,252
7,706
7,7069,2523,734-418-954-128-1496,7167,14011,34426,07542,79140,90539,32337,1412,71622,70935,8825,00035,88238,57138,57140,811-1,182-7,67705,0005,0005,0005,0005,0005,000
   Common Stock
107,675
107,762
107,825
107,999
108,210
108,529
0
56,268
18,545
0
1
130
0
1
0
3
3
3
3
3
3
4
0
0
1
1
0
0
0
0
0
1
100000110043333330101301018,54556,2680108,529108,210107,999107,825107,762107,675
   Retained Earnings 
-29
57
121
294
505
825
0
1,393
-19,664
-21,719
-37,474
852
-39,587
-3,343
-39,587
-64,556
-88,015
-69,719
-68,682
-67,119
-64,179
-85,666
-107,409
-112,171
-115,851
-126,117
-127,344
-128,413
-128,402
-129,238
-141,523
-143,893
-143,893-141,523-129,238-128,402-128,413-127,344-126,117-115,851-112,171-107,409-85,666-64,179-67,119-68,682-69,719-88,015-64,556-39,587-3,343-39,587852-37,474-21,719-19,6641,393082550529412157-29
   Capital Surplus 
0
0
0
0
0
0
0
0
0
3,639
3,930
4,147
9,583
12,680
9,583
0
78,005
106,154
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000106,15478,00509,58312,6809,5834,1473,9303,639000000000
   Treasury Stock00000000000000000000000000000000
   Other Stockholders Equity 
-102,646
-102,819
-102,946
-103,293
-103,715
-104,354
0
-1,393
24,727
62,681
75,890
-982
1,458,934,706
-2,021,696,657
76,293
826
89,496
106,154
107,187
107,930
108,786
115,427
121,638
122,195
125,466
128,815
130,117
130,354
130,899
135,955
153,692
154,579
154,579153,692135,955130,899130,354130,117128,815125,466122,195121,638115,427108,786107,930107,187106,15489,49682676,293-2,021,696,6571,458,934,706-98275,89062,68124,727-1,3930-104,354-103,715-103,293-102,946-102,819-102,646



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-6,325
Operating Income-6,325-6,325
 
Operating Expense (+$)
Research Development1,969
Selling General Administrative4,355
Selling And Marketing Expenses0
Operating Expense6,3256,325
 
Net Interest Income (+$)
Interest Income0
Interest Expense-51
Other Finance Cost-0
Net Interest Income-51
 
Pretax Income (+$)
Operating Income-6,325
Net Interest Income-51
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-6,464-6,185
EBIT - interestExpense = -6,565
-6,464
-6,118
Interest Expense51
Earnings Before Interest and Taxes (EBIT)-6,515-6,414
Earnings Before Interest and Taxes (EBITDA)-6,325
 
After tax Income (+$)
Income Before Tax-6,464
Tax Provision--296
Net Income From Continuing Ops-6,168-6,168
Net Income-6,168
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses6,325
Total Other Income/Expenses Net-13951
 

Technical Analysis of 180 Life Sciences Corp
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of 180 Life Sciences Corp. The general trend of 180 Life Sciences Corp is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine 180 Life Sciences Corp's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. 180 Life Sciences Corp Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of 180 Life Sciences Corp.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.93 < 1.27 < 1.3.

The bearish price targets are: 0.827 > 0.658.

Know someone who trades $ATNF? Share this with them.πŸ‘‡

180 Life Sciences Corp Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of 180 Life Sciences Corp. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

180 Life Sciences Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of 180 Life Sciences Corp.

180 Life Sciences Corp Daily Moving Average Convergence/Divergence (MACD) Chart180 Life Sciences Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of 180 Life Sciences Corp. The current adx is .

180 Life Sciences Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of 180 Life Sciences Corp.

180 Life Sciences Corp Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of 180 Life Sciences Corp.

180 Life Sciences Corp Daily Relative Strength Index (RSI) Chart180 Life Sciences Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of 180 Life Sciences Corp.

180 Life Sciences Corp Daily Stochastic Oscillator Chart180 Life Sciences Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of 180 Life Sciences Corp.

180 Life Sciences Corp Daily Commodity Channel Index (CCI) Chart180 Life Sciences Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of 180 Life Sciences Corp.

180 Life Sciences Corp Daily Chande Momentum Oscillator (CMO) Chart180 Life Sciences Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of 180 Life Sciences Corp.

180 Life Sciences Corp Daily Williams %R Chart180 Life Sciences Corp Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of 180 Life Sciences Corp.

180 Life Sciences Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of 180 Life Sciences Corp.

180 Life Sciences Corp Daily Average True Range (ATR) Chart180 Life Sciences Corp Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of 180 Life Sciences Corp.

180 Life Sciences Corp Daily On-Balance Volume (OBV) Chart180 Life Sciences Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of 180 Life Sciences Corp.

180 Life Sciences Corp Daily Money Flow Index (MFI) Chart180 Life Sciences Corp Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for 180 Life Sciences Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-02-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-03-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-24MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-16MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-27STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

180 Life Sciences Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of 180 Life Sciences Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.830
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of 180 Life Sciences Corp with someone you think should read this too:
  • Are you bullish or bearish on 180 Life Sciences Corp? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about 180 Life Sciences Corp? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about 180 Life Sciences Corp

I send you an email if I find something interesting about 180 Life Sciences Corp.


Comments

How you think about this?

Leave a comment

Stay informed about 180 Life Sciences Corp.

Receive notifications about 180 Life Sciences Corp in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.